Recent advances of DNAzyme-based nanotherapeutic platform in cancer gene therapy

Wendi Huo; Xiaona Li; Bei Wang; Haoran Zhang; Jinchao Zhang; Xinjian Yang; Yi Jin

doi:10.1007/s41048-020-00123-w

Volume 6 Issue 6

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Biophysics Reports > 2020 > 6(6): 256-265

Wendi Huo, Xiaona Li, Bei Wang, Haoran Zhang, Jinchao Zhang, Xinjian Yang, Yi Jin. Recent advances of DNAzyme-based nanotherapeutic platform in cancer gene therapy[J]. Biophysics Reports, 2020, 6(6): 256-265. doi: 10.1007/s41048-020-00123-w

Citation:

Wendi Huo, Xiaona Li, Bei Wang, Haoran Zhang, Jinchao Zhang, Xinjian Yang, Yi Jin. Recent advances of DNAzyme-based nanotherapeutic platform in cancer gene therapy[J]. Biophysics Reports, 2020, 6(6): 256-265. doi: 10.1007/s41048-020-00123-w

Citation:

PDF (1395 KB)

Recent advances of DNAzyme-based nanotherapeutic platform in cancer gene therapy

doi: 10.1007/s41048-020-00123-w

1 College of Basic Medical Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory-autoimmune Diseases of Hebei Province, Hebei University, Baoding 071002, Hebei, China
2 College of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Institute of Life Science and Green Development, Hebei University, Baoding 071002, Hebei, China

Funds: The work was supported by the National Natural Science Foundation of China (21603051), the Natural Science Foundation of Hebei Province (B2018201221, B2018201157), Hebei Youth top talent project, Key Projects of Education Department of Hebei Province (ZD2018036), and Undergraduate Innovation and Entrepreneurship Training Program of Hebei University (2020351).

More Information

Corresponding author: Xinjian Yang, Yi Jin
Received Date: 26 June 2020
Rev Recd Date: 08 October 2020
Publish Date: 10 March 2021

Abstract

Abstract

Deoxyribozyme (or denoted as DNAzyme), which is produced by in vitro screening technology, has gained extensive research interest in the field of biomedicine due to its high catalytic activity and structure identification. This review introduces the structural characteristics of RNA-cleaving DNAzyme and its application potential in cancer gene therapy, which plays a significant role in cancer-related gene inactivation by specifically cleaving target mRNA and inhibiting the expression of the corresponding protein. However, the low delivery efficiency and cellular uptake hindered the widespread usage of DNAzyme in gene therapy of cancers. Emerging nanotechnology holds great promise for DNAzyme to overcome these obstacles. This review mainly focuses on DNAzyme-based nanotherapeutic platforms in gene therapy of cancers, including oncogene antagonism therapy, treatment resistance gene therapy, immunogene therapy, and antiangiogenesis gene therapy. We also revealed the potential of DNAzymebased nanotherapeutic platforms as emerging cancer therapy approaches and their security issues.
- DNAzyme,
- Cancer therapy,
- Gene-silencing,
- Nanocarrier

FullText(HTML)

References(61)

References

Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ Jr (2000) An informatics approach identifying markers of chemosensitivity in human cancer cell Lines. Cancer Res 60(21):6101-6110

Cai H, Cho EA, Li Y, Sockler J, Parish CR, Chong BH, Edwards J, Dodds TJ, Ferguson PM, Wilmott JS, Scolyer RA, Halliday GM, Khachigian LM (2018) Melanoma protective antitumor immunity activated by catalytic DNA. Oncogene 37(37):5115-5126

Cai H, Fernando SS, Leonel P, Wang B, Margaret P, Miles PD, Ghassan JM, Roland S, Christopher RP, Beng HC, Graham JL, Tak-Wah W, Colin NC, Douglas JF, Fergal JM, Ross SB, Halliday GM, Levon MK (2012) DNAzyme targeting c-jun suppresses skin cancer growth. Sci Transl Med 4(139):139ra82-139ra82

Cao T, Wang Y, Tao Y, Zhang L, Zhou YL, Zhang XX, Heyman JA, Weitz DA (2020) DNAzyme-powered nucleic acid release from solid supports. Chem Commun (Camb)56(4):647-650

Cho E-A, Moloney FJ, Cai H, Au-Yeung A, China C, Scolyer RA, Yosufi B, Raftery MJ, Deng JZ, Morton SW, Hammond PT, Arkenau H-T, Damian DL, Francis DJ, Chesterman CN, Barnetson RSC, Halliday GM, Khachigian LM (2013) Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma:a phase 1 first-in-human trial (DISCOVER). The Lancet 381(9880):1835-1843

Cully M (2017) Cancer:tumour vessel normalization takes centre stage. Nat Rev Drug Discov 16(2):87

Dass CR, Choong PF, Khachigian LM (2008a) DNAzyme technology and cancer therapy:cleave and let die. Mol Cancer Ther 7(2):243-251

Dass CR, Khachigian LM, Choong PF (2008b) c-Jun knockdown sensitizes osteosarcoma to doxorubicin. Mol Cancer Ther 7(7):1909-1912

Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics:an emerging treatment modality for cancer. Nat Rev Drug Discov 7(9):771-782

Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161-174

Fan H, Zhao Z, Yan G, Zhang X, Yang C, Meng H, Chen Z, Liu H, Tan W (2015) A smart DNAzyme-MnO₂ nanosystem for efficient gene silencing. Angew Chem Int Ed Engl 54(16):4801-4805

Farrokhi F, Karami Z, Esmaeili-Mahani S, Heydari A (2018) Delivery of DNAzyme targeting c-Myc gene using b-cyclodextrin polymer nanocarrier for therapeutic application in human breast cancer cell line. J Drug Deliv Sci Tec 47:477-484

Feng J, Xu Z, Liu F, Zhao Y, Yu W, Pan M, Wang F, Liu X (2018) Versatile catalytic deoxyribozyme vehicles for multimodal imaging-guided efficient gene regulation and photothermal therapy. ACS Nano 12(12):12888-12901

Fokina AA, Meschaninova MI, Durfort T, Venyaminova AG, Francois JC (2012) Targeting insulin-like growth factor I with 10-23 DNAzymes:2'-O-methyl modifications in the catalytic core enhance mRNA cleavage. Biochemistry 51(11):2181-2191

Fu S, Sun L (2015) DNAzyme-based therapeutics for cancer treatment. Future Med Chem 7(13):1701-1707

Gao P, Zhou G, Zhang Q, Li H, Mu K, Yuan Y, Zhang J, Wang B (2006) Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA. Chinese J Physiol 49(2):96-103

Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13(12):871-882

Haabeth OA, Tveita AA, Fauskanger M, Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic Z, Corthay A, Bogen B (2014) How do CD4⁺T cells detect and eliminate tumor cells that either lack or express MHC class II molecules⁺Front Immunol 5(5):174. https://doi.org/10.3389/fimmu.2014.00174

Hallett MA, Teng B, Hasegawa H, Schwab LP, Seagroves TN, Pourmotabbed T (2013) Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer. Breast Cancer Res 15(1):R12. https://doi.org/10.1186/bcr3385

He ZM, Zhang PH, Li X, Zhang JR, Zhu JJ (2016) A Targeted DNAzyme-nanocomposite probe equipped with built-in Zn²⁺ arsenal for combined treatment of gene regulation and drug delivery. Sci Rep 6:22737. https://doi.org/10.1038/srep22737

Hollenstein M (2015) DNA catalysis:the chemical repertoire of DNAzymes. Molecules 20(11):20777-20804

Jang D, Baek YM, Park H, Hwang YE, Kim DE (2018) Dual effects of a CpG-DNAzyme targeting mutant EGFR transcripts in lung cancer cells:TLR9 activation and EGFR downregulation. BMB Rep 51(1):27-32

Jin Y, Li Z, Liu H, Chen S, Wang F, Wang L, Li N, Ge K, Yang X, Liang X-J, Zhang J (2017) Biodegradable, multifunctional DNAzyme nanoflowers for enhanced cancer therapy. NPG Asia Mater 9(3):e365

Jin Y, Liang L, Sun X, Yu G, Chen S, Shi S, Liu H, Li Z, Ge K, Liu D, Yang X, Zhang J (2018) Deoxyribozyme-nanosponges for improved photothermal therapy by overcoming thermoresistance. NPG Asia Mater 10:373-384

Jin Y, Wang H, Li X, Zhu H, Sun D, Sun X, Liu H, Zhang Z, Cao L, Gao C, Wang H, Liang XJ, Zhang J, Yang X (2020) Multifunctional DNA polymer-assisted upconversion therapeutic nanoplatform for enhanced photodynamic therapy. ACS Appl Mater Inter 12(24):26832-26841

Khachigian LM (2019) Deoxyribozymes as catalytic nanotherapeutic agents. Cancer Res 79(5):879-888

Khachigian LM, Cai H, Moloney FJ, Parish CR, Chong BH, Stocker R, Barnetson RS, Halliday GM (2012) Destroying c-jun messenger:new insights into biological mechanisms of DNAzyme function. Oncotarget 3(6):594-595

Lan T, Furuya K, Lu Y (2010) A highly selective lead sensor based on a classic lead DNAzyme. Chem Commun (Camb) 46(22):3896-3898

Li D, Mo F, Wu J, Huang Y, Zhou H, Ding S, Chen W (2018) A multifunctional DNA nano-scorpion for highly efficient targeted delivery of mRNA therapeutics. Sci Rep 8(1):10196. https://doi.org/10.1038/s41598-018-28542-3

Liu J, Li Y (2007) A DNAzyme catalytic beacon sensor for paramagnetic Cu²⁺ions in aqueous solution with high sensitivity and selectivity. J Am Chem Soc 129(32):9838-9839

Lugano R, Ramachandran M, Dimberg A (2019) Tumor angiogenesis:causes, consequences, challenges and opportunities. Cell Mol Life Sci 77(21):1745-1770

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics:a review. J Control Release 65(1-2):271-284

Meng L, Ma W, Lin S, Shi S, Li Y, Lin Y (2019) Tetrahedral DNA nanostructure-delivered DNAzyme for gene silencing to suppress cell growth. ACS Appl Mater Inter 11(7):6850-6857

Peng S, Bie B, Sun Y, Liu M, Cong H, Zhou W, Xia Y, Tang H, Deng H, Zhou X (2018) Metal-organic frameworks for precise inclusion of single-stranded DNA and transfection in immune cells. Nat Commun 9(1):1293. https://doi.org/10.1038/s41467-018-03650-w

Peng Y, Zhang P, Huang X, Yan Q, Wu M, Xie R, Wu Y, Zhang M, Nan Q, Zhao J, Li A, Xiong J, Ren Y, Bai Y, Chen Y, Liu S (2016) Direct regulation of foxk1 by c-jun promotes proliferation, invasion and metastasis in gastric cancer cells. Cell Death Dis 7(11):e2480. https://doi.org/10.1038/cddis.2016.225

Ramos P, Bentires-Alj M (2015) Mechanism-based cancer therapy:resistance to therapy, therapy for resistance. Oncogene 34(28):3617-3626

Raphael I, Joern RR, Forsthuber TG (2020) Memory CD4⁺T cells in immunity and autoimmune diseases. Cells 9(3):531. https://doi.org/10.3390/cells9030531

Ren T, Deng Z, Liu H, Li X, Li J, Yuan J, He Y, Liu Q, Yang Y, Zhong S (2019) Co-delivery of DNAzyme and a chemotherapy drug using a DNA tetrahedron for enhanced anticancer therapy through synergistic effects. New J Chem 43(15):14020-14027

Roma-Rodrigues C, Rivas-Garcia L, Baptista PV, Fernandes AR (2020) Gene therapy in cancer treatment:why go nano? Pharmaceutics 12(3):233. https://doi.org/10.3390/pharmaceutics12030233

Santoro SW, Joyce GF (1997) A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 94(9):4262-4266

Shen L, Zhou Q, Wang Y, Liao W, Chen Y, Xu Z, Yang L, Sun LQ (2013) Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1(VEGFR-1)- targeted DNAzyme. Mol Med 19(1):377-386

Silverman SK (2005) In vitro selection, characterization, and application of deoxyribozymes that cleave RNA. Nucleic Acids Res 33(19):6151-6163

Silverman SK (2016) Catalytic DNA:scope, applications, and biochemistry of deoxyribozymes. Trends Biochem Sci 41(7):595-609

Sun SP, Liu CP, Huang IP, Chu CH, Chung MF, Cheng SH, Lin SY, Lo LW (2017) A co-delivery nanosystem of chemotherapeutics and DNAzyme overcomes cancer drug resistance and metastasis. Nano Futures 1(3):035005. https://doi.org/10.1088/2399-1984/aa996f

Sun X, Jin Y, Wang H, Feng N, Li Z, Liu D, Ge K, Liu H, Zhang J, Yang X (2018) A NIR-light activated nanoplatform for sensitizing triple negative breast cancer against therapeutic resistance to enhance the treatment effect. J Mater Chem B 6(43):6950-6956

Tan ML, Dunstan DE, Friedhuber AM, Choong PF, Dass CR (2010) A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site. J Control Release 144(2):196-202

Wang H, Chen Y, Wang H, Liu X, Zhou X, Wang F (2019a) DNAzyme-loaded metal-organic frameworks (MOFs) for selfsufficient gene therapy. Angew Chem Int Ed Engl 58(22):7380-7384

Wang J, Wang H, Wang H, He S, Li R, Deng Z, Liu X, Wang F (2019b) Nonviolent self-catabolic DNAzyme nanosponges for smart anticancer drug delivery. ACS Nano 13(5):5852-5863

Wang X, Dai J, Wang X, Hu Q, Huang K, Zhao Z, Lou X, Xia F (2019c) MnO₂-DNAzyme-photosensitizer nanocomposite with AIE characteristic for cell imaging and photodynamic-gene therapy. Talanta 202(1):591-599

Wang X, Zhang L, Ding N, Yang X, Zhang J, He J, Li Z, Sun LQ (2015) Identification and characterization of DNAzymes targeting DNA methyltransferase I for suppressing bladder cancer proliferation. Biochem Biophys Res Commun 461(2):329-333

Wiktorska M, Papiewska-Pająk L, Okruszek A, Sacewicz Hofman L, Niewiarowska J (2010) DNAzyme as an efficient tool to modulate invasiveness of human carcinoma cells. Acta Biochimica Polonica 57(3):269-275

Wu Y, Yu L, Mcmahon R, Rossi J, Forman S, Snyder D (1999) Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum Gene Ther 10(17):2847-2857

Xiao Y, Shi K, Qu Y, Chu B, Qian Z (2019) Engineering nanoparticles for targeted delivery of nucleic acid therapeutics in tumor. Mol Ther Methods Clin Dev 12:1-18

Xing Z, Gao S, Duan Y, Han H, Li L, Yang Y, Li Q (2015) Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer. Int J Nanomed 10(1):5715-5727

Xu Z, Yang L, Sun L, Cao Y (2012) Use of DNAzymes for cancer research and therapy. Chinese Sci Bull 57(26):3404-3408

Yang L, Liu L, Xu Z, Liao W, Feng D, Dong X, Xu S, Xiao L, Lu J, Luo X, Tang M, Ann MB, Dong Z, Sun L, Cao Y (2015) EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma. Oncotarget 6(8):5804-5817

Yu X, Yang L, Cairns MJ, Dass C, Saravolac E, Li X, Sun L (2014) Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme. Oncotarget 5(19):9039-9048

Zhang L, Zhao W, Liang C, Yi X, Pei Y, Lin Y, He J, Li W (2016) VEGFR-1 targeted DNAzyme via transcatheter arterial delivery influences tumor vasculature assessed through dynamic contrast-enhanced magnetic resonance imaging. Oncol Rep 36(3):1339-1344

Zhou W, Ding J, Liu J (2017) Theranostic DNAzymes. Theranostics 7(4):1010-1025

Zhou W, Saran R, Chen Q, Ding J, Liu J (2016) A new Na⁺dependent RNA-cleaving DNAzyme with over 1000-fold rate acceleration by ethanol. Chembiochem 17(2):159-163

Zokaei E, Badoei-Dalfrad A, Ansari M, Karami Z, Eslaminejad T, Nematollahi-Mahani SN (2019) Therapeutic potential of DNAzyme loaded on chitosan/cyclodextrin nanoparticle to recovery of chemosensitivity in the MCF-7 cell line. Appl Biochem Biotechnol 187(3):708-723

Supplements(0)

Relative Articles

Cited By

Proportional views